ArticleBMC infectious diseases2014

The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.

Johanna C Nissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.